Table 2.
Entire Cohort N=617 |
Study 117 N=183 |
Study 224 N=105 |
Study 3 N=326 |
P-Value | |
---|---|---|---|---|---|
Optimal MAP (mean±SD, mmHg) | 78 ± 11 | 74 ± 12 | 75 ± 10 | 80 ± 11 | <0.001 |
LLA (mmHg) | 65 ± 12 | 63 ± 11 | 66 ± 13 | 66 ± 12 | 0.024 |
ULA (mmHg) | 84 ± 11 | 81 ± 10 | 82 ± 9 | 86 ± 12 | 0.002 |
Patients whose crossed LLA | 434 (71%) | 141 (77%) | 70 (67%) | 223 (68%) | 0.074 |
Patients whose crossed ULA | 323 (52%) | 102 (56%) | 58 (55%) | 163 (50%) | 0.387 |